AIHealthcare

Oncompass Medicine is a Hungarian precision-oncology company founded in Budapest in 2003. It develops molecular diagnostic and clinical decision-support medical devices and software intended to help oncologists select personalized, targeted cancer treatments. Its technology uses genomic and biomedical evidence, including artificial-intelligence-based analysis, to identify molecular targets and rank treatment options. The company became part of U.S.-based Genomate Health in January 2026; the acquisition amount was not disclosed. Oncompass has established a market position as an early Hungarian pioneer in AI-supported precision oncology, with more than two decades of oncology research, diagnostics, and clinical operations in Hungary and Europe.